Repligen
RGEN
#2563
Rank
$6.67 B
Marketcap
$118.56
Share price
0.21%
Change (1 day)
-7.73%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2025 (TTM): $0.87

According to Repligen 's latest financial reports the company's current EPS (TTM) is $0.87. an increase over its 2024 EPS that were of -$0.45.

EPS history for Repligen from 2012 to 2025

Annual EPS

Year EPS Change
2025$0.85-288.89%
2024-$0.45-160%
2023$0.75-77.68%
2022$3.3643.59%
2021$2.34105.26%
2020$1.14153.33%
2019$0.4518.42%
2018$0.38-47.95%
2017$0.73108.57%
2016$0.3520.69%
2015$0.2916%
2014$0.25-48.98%
2013$0.496.52%
2012$0.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
$1.36 56.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$17.77 1,942.53%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$8.22 844.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$3.46 297.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-$0.44-150.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
$2.12 143.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$4.82 454.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$0.52-40.23%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$1.82 109.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-$2.95-439.08%๐Ÿ‡บ๐Ÿ‡ธ USA